HMB supplement for head and neck cancer surgery
Part of Cancer clinical trials.
This trial tests whether taking HMB (a supplement that may help reduce inflammation) can improve recovery and outcomes in people with head and neck cancer who are scheduled for surgery to remove their tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with head and neck cancer.
- You are being treated at an outpatient clinic for head and neck cancer.
- Your doctor plans to do surgery to remove the tumor, and the goal is to cure the cancer.
- You do not have cancer of the face, skin, sinuses, or thyroid.
- You are not receiving chemotherapy or radiation before surgery, or only palliative care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether patients with head and neck squamous cell carcinoma who had a good response to chemotherapy and immunotherapy before surgery can safely have less radiation after surgery. It aims to reduce side effects while keeping treatment effective.
This trial tests whether adding an AHCC supplement to standard treatment can improve outcomes for people with HPV-positive head and neck cancer. It is for patients who have had surgery and have certain high-risk features, like positive margins or cancer spread to lymph nodes.
This trial tests whether a special protein supplement can help prevent or reduce painful mouth sores (oral mucositis) that often develop when people receive radiation therapy for head and neck cancer. Researchers believe extra protein may help the mouth heal better during treatment.
This trial tests whether a special form of megestrol acetate can help prevent cancer from coming back in people with high-risk head and neck cancer who have had surgery. It is for patients who need additional treatment with radiation or chemoradiation after their operation.
This trial tests whether adding postbiotics (beneficial bacteria byproducts) to the standard immunotherapy drug pembrolizumab can improve your immune system's response against advanced or metastatic head and neck squamous cell carcinoma.
This study tests whether patients recovering from head and neck cancer surgery can safely do supervised exercise exercises at home. The program aims to help you regain strength and function during your recovery.
Hear when a new Head and Neck Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.